INOVIO Reports Second Quarter 2024 Financial Results and Recent Business HighlightsPRNewsWire • 08/08/24
Inovio Receives Advanced Therapy Medicinal Product Certificate from European Medicines Agency for Quality and Non-Clinical Data for Lead Candidate INO-3107PRNewsWire • 07/25/24
INO-3107 Awarded the Innovation Passport Designation Under U.K. Government's Innovative Licensing and Access PathwayPRNewsWire • 07/11/24
Inovio Pharmaceuticals, Inc. (INO) H.C. Wainwright 2nd Annual BioConnect Investor Conference (Transcript)Seeking Alpha • 05/20/24
Inovio Pharmaceuticals, Inc. (INO) Presents at 2024 RBC Capital Markets Global Healthcare Conference (Transcript)Seeking Alpha • 05/15/24
Inovio Pharmaceuticals, Inc. (INO) The Citizens JMP Life Sciences Conference (Transcript)Seeking Alpha • 05/14/24
INOVIO Reports First Quarter 2024 Financial Results and Recent Business HighlightsPRNewsWire • 05/13/24
INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded WarrantsPRNewsWire • 04/15/24
INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn MedicinePRNewsWire • 03/26/24